Related references
Note: Only part of the references are listed.The prospects for personalized medicine in drug development and drug therapy
J. Woodcock
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure
Tanya Hansotia et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The cerebrocortical response to hyperinsulinemia is reduced in overweight humans:: A magnetoencephalographic study
Otto Tschritter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Role of the forkhead protein FoxO1 in β cell compensation to insulin resistance
H Okamoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Critical nodes in signalling pathways: insights into insulin action
CM Taniguchi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Genetic prediction of future type 2 diabetes
V Lyssenko et al.
PLOS MEDICINE (2005)
Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-α
M Federici et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Common polymorphisms in the genes regulating the early insulin signalling pathway:: effects on weight change and the conversion from impaired glucose tolerance to Type 2 diabetes.: The Finnish Diabetes Prevention Study
O Laukkanen et al.
DIABETOLOGIA (2004)
G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells
M Federici et al.
CIRCULATION (2004)
The G972R variant of the insulin receptor substrate-1 (IRS-1) gene is associated with insulin resistance in uncomplicated obese subjects evaluated by hyperinsulinemic-euglycemic clamp
MG Baroni et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2004)
The insulin receptor substrate-1 Gly972Arg polymorphism is not associated with Type 2 diabetes mellitus in two population-based studies
RM van Dam et al.
DIABETIC MEDICINE (2004)
Association testing in 9,000 people fails to confirm the association of the insulin receptor substrate-1 G972R polymorphism with type 2 diabetes
JC Florez et al.
DIABETES (2004)
The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes
G Sesti et al.
DIABETES CARE (2004)
Gly972Arg variant in the insulin receptor substrate-1 gene and association with Type 2 diabetes:: a meta-analysis of 27 studies
A Jellema et al.
DIABETOLOGIA (2003)
Counteraction of type 1 diabetic alterations by engineering skeletal muscle to produce insulin - Insights from transgenic mice
E Riu et al.
DIABETES (2002)
Defects of the insulin receptor substrate (IRS) system in human metabolic disorders
G Sesti et al.
FASEB JOURNAL (2001)
Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance
A Zisman et al.
NATURE MEDICINE (2000)
The Gly→Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells
ML Hribal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Share Paper
